CN1820016A - 新型14和15元环化合物 - Google Patents

新型14和15元环化合物 Download PDF

Info

Publication number
CN1820016A
CN1820016A CNA200480019644XA CN200480019644A CN1820016A CN 1820016 A CN1820016 A CN 1820016A CN A200480019644X A CNA200480019644X A CN A200480019644XA CN 200480019644 A CN200480019644 A CN 200480019644A CN 1820016 A CN1820016 A CN 1820016A
Authority
CN
China
Prior art keywords
compound
alkyl
hydrogen
optionally substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200480019644XA
Other languages
English (en)
Chinese (zh)
Inventor
S·阿利霍兹克
A·伯迪克
R·L·亚维斯特
G·拉扎雷夫斯基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Fidelta doo
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Institut doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Institut doo filed Critical Glaxo Group Ltd
Publication of CN1820016A publication Critical patent/CN1820016A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CNA200480019644XA 2003-05-13 2004-05-11 新型14和15元环化合物 Pending CN1820016A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0310992.3A GB0310992D0 (en) 2003-05-13 2003-05-13 Novel compounds
GB0310992.3 2003-05-13

Publications (1)

Publication Number Publication Date
CN1820016A true CN1820016A (zh) 2006-08-16

Family

ID=9957987

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200480019644XA Pending CN1820016A (zh) 2003-05-13 2004-05-11 新型14和15元环化合物

Country Status (12)

Country Link
US (1) US20080221158A1 (https=)
EP (1) EP1633765B1 (https=)
JP (1) JP2006528668A (https=)
CN (1) CN1820016A (https=)
AR (1) AR044310A1 (https=)
AT (1) ATE378347T1 (https=)
CA (1) CA2525459A1 (https=)
CL (1) CL2004001005A1 (https=)
DE (1) DE602004010110T2 (https=)
ES (1) ES2295865T3 (https=)
GB (1) GB0310992D0 (https=)
WO (1) WO2004101590A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540504A (ja) * 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用な４’’アミノ結合マクロライド
GB201706299D0 (en) * 2017-04-20 2017-06-07 Novintum Biotechnology Gmbh Compounds
WO2018193126A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as antibacterial agents
WO2021195126A1 (en) 2020-03-24 2021-09-30 Burnet Michael W Anti-infective and anti-viral compounds and compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
AU710532B2 (en) * 1996-05-07 1999-09-23 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
DE602004010110T2 (de) 2008-09-11
EP1633765B1 (en) 2007-11-14
ES2295865T3 (es) 2008-04-16
ATE378347T1 (de) 2007-11-15
CA2525459A1 (en) 2004-11-25
US20080221158A1 (en) 2008-09-11
DE602004010110D1 (de) 2007-12-27
EP1633765A1 (en) 2006-03-15
AR044310A1 (es) 2005-09-07
JP2006528668A (ja) 2006-12-21
CL2004001005A1 (es) 2005-03-18
GB0310992D0 (en) 2003-06-18
WO2004101590A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
CN1052984C (zh) 新的红霉素衍生物、其制备方法及其作为药物的应用
CN100335491C (zh) 具有抗炎活性的大环内酯化合物
CN1264837C (zh) 喹诺酮抗微生物剂、其组合物和应用
CN1179970C (zh) 嘌呤衍生物
CN1612888A (zh) 大环内酯类化合物
CN1126997A (zh) 红霉素的新型衍生物，其制备方法及作为药物的应用
CN1065069A (zh) 新的红霉素衍生物的制备方法
CN1538967A (zh) 杂环化合物和以其为有效成分的抗肿瘤药
CN1151165C (zh) 具有抗炎活性的大环内酯
CN1446218A (zh) 苯并咪唑衍生物,它们的制备方法以及它们的治疗应用
CN1436079A (zh) 咪唑并吡啶和咪唑并嘧啶抗病毒剂
CN1400975A (zh) 嘌呤衍生物
CN1237183A (zh) 具有抗细菌活性的6－0－取代的酮基内酯类化合物
CN1064080A (zh) 肽类化合物、其制备方法及含有这类化合物的药物组合物
CN1344160A (zh) 用作生长激素促分泌剂的杂环芳族化合物
CN1072219C (zh) 二氮杂䓬酮、其生产和用途
CN1659178A (zh) 6、11二环红霉素衍生物
CN1096784A (zh) 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂
CN1048242C (zh) 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物
CN1250544C (zh) 吡啶并芳基苯基噁唑烷酮抗菌剂和相关组合物及方法
CN1278266A (zh) 6,11－桥连红霉素衍生物
CN1226893A (zh) 精选的K－252a衍生物
CN1205704A (zh) 2,7－取代的八氢－吡咯并[1,2－a]吡嗪衍生物
CN101052633A (zh) 制备吲唑化合物的方法
CN1045976A (zh) 新的取代的替考拉宁的烷基酰胺衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20060816